A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)

Conditions: Candidiasis, Esophageal; Candidiasis, Invasive; AspergillosisIntervention: Drug: CaspofunginSponsor: Merck Sharp & Dohme Corp.Completed - verified February 2015

http://clinicaltrials.gov/ct2/show/NCT01165320?lup_s=02%2F18%2F2015&lup_d=30

Source: ClinicalTrials.gov - July 15, 2010 Category: Research Source Type: clinical trials